Lars Sondergaard
Latest contributions
Contemporary best clinical practice for TAVI
18 May 2023 – From EuroPCR 2023
This interactive session is designed to show how a good pre-procedural assessment can facilitate the planning of a procedure. It also shows how a certain valve can be best suited for patients with certain phenotypes, and finally how to fully optimise the procedure to obtain the...
TAVI 1: durability, mismatch and challenging anatomy
18 May 2023 – From EuroPCR 2023
Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.
Which valve for which patient? - Part 1: simple anatomy
17 May 2023 – From EuroPCR 2023
Explore this session to gain insights into the influence of valve design on hemodynamic performance and durability, understand its implications for risk factors associated with TAVI in bicuspid aortic valves, and grasp the relationship between valve design, implantation techniques, and the emergence of new conduction abnormalities...
Which valve for which patient? - Part 2: complex anatomy
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.
PFO closure: safety, challenging anatomies and complications
17 May 2023 – From EuroPCR 2023
Disocover these cases to master PFO closure! Understand indications and patient selection, execute safe procedures, and navigate pitfalls with effective management strategies.
What does TRILUMINATE Pivotal mean for my patients?
18 May 2023 – From EuroPCR 2023
Francesco Maisano joins Lars Sondergaard for a short but rich exchange of views on the TRILUMINATE Pivotal trial while EuroPCR 2023 is in full swing. This randomized trial, comparing TriClip versus medical treatment, was the first of its kind, and its initial outcomes are already very...
EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI
16 May 2023 – From EuroPCR 2023
Discover the conclusions of various studies and registries about TAVI: 5-year outcomes with the ACURATE neo2 valve: the Neo AS CE-mark study; TAVR in patients with cardiogenic shock which evaluated outcomes of consecutive TAVRs in patients with CS using contemporary SAPIEN 3 and SAPIEN 3 ultra...
Learnings and perspectives from the COAPT trial, 5-year follow-up
16 May 2023 – From EuroPCR 2023
Francesco Maisano and Lars Sondergaard meet up between 2 sessions of EuroPCR 2023 to discuss the 5-year results of the COAPT trial and share their key messages with us.
One of the main points to note is that 95 % of patients treated with MitraClip experiencing reduced...
How should I treat? – TAVI with a self-expanding aortic valve in bicuspid aortic valve stenosis
09 Mar 2023
A 73-year-old male patient was referred for treatment of severe symptomatic aortic valve stenosis. This case describes the decision-making in performing TAVI with a self-expanding aortic valve in a patient with bicuspid aortic valve stenosis and peripheral arterial disease.
Author
Author
TAVI in small annulus and coronary artery disease - Session with LIVE case
19 Feb 2023 – From PCR Tokyo Valves 2023
Watch the complex case of an 84-year-old woman with hypertension, type 2 diabetes and coronary artery disease who presented with worsening NYHA class II-III exertional dyspnoea, but no angina, and find out how she was treated LIVE.
PCR Tokyo Valves 2023 Closing Ceremony
19 Feb 2023 – From PCR Tokyo Valves 2023
This closing ceremony of the 2023 edition of the PCR Tokyo Valves is the occasion to unveil the results of the best abstract and best case competitions and to congratulate the finalists. It is also the moment to take stock of this excellent edition, to thank...
PCR Tokyo Valves 2023: Opening Ceremony
18 Feb 2023 – From PCR Tokyo Valves 2023
Follow the presentation broadcasted at the opening of the 2023 edition of PCR Tokyo Valves: 3 days dedicated to the 3 valves and focused on interaction, exchange and practice. Then, listen to the Course directors' delight at finally having a face-to-face Course again, especially since this...
TAVI with advanced imaging techniques - LIVE case
18 Feb 2023 – From PCR Tokyo Valves 2023
A 93-year-old female, with chronic kidney disease (GFR:34), diabetes, first degree AV block, present a symptomatic severe calcified aortic stenosis. Watch the operators as they implant an Evolut pro 26mm, guided by ICE in order to check the position of the distal part of the valve with...
The role and benefit of WATCHMAN FLX in stroke prevention
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, discover WATCHMAN FLX's numerous benefits for stroke prevention, covering topics such as patient indications for LAAC, the importance of Heart-Brain Team collaboration and post-procedural management insights.
PFO closure
17 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to learn procedural tips and tricks and explore the role of PFO treatment for stroke prevention. Discover the evidence for PFO closure, when it should be considered, pre, intra and post procederal management, and common procedural complications.
Future perspectives of LAAC
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into the evolving landscape of Left Atrial Appendage Closure (LAAC). Explore evidence, optimal patient criteria, and comprehensive preprocedural assessments for innovative LAAO devices.
The role of left atrial appendage closure in stroke prevention
07 Feb 2023
Watch the replay of the 4th of #PCRtokyo 2022’s six live webinars. You’ll learn all about ‘The role of left atrial appendage closure in stroke prevention'
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
Transcatheter tricuspid interventions: emerging evidence
29 Nov 2022 – From PCR London Valves 2022
Get insights into the latest studies regarding transcatheter tricuspid interventions with this selection of presentations on TriCLASP, bRIGHT, PASTE, EVALUATE, and more!
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
Surgical and transcatheter tricuspid intervention: state of the art - LIVE case
29 Nov 2022 – From PCR London Valves 2022
In this PCR London Valves 2022 session, follow 3 stunning case treatments:
- Part 1: Triscupid TEER (Live)
A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
They performed...
Contemporary best clinical practice for TAVI
28 Nov 2022 – From PCR London Valves 2022
Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.
Challenging scenarios: bicuspid aortic valves
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.
TAVI in complex situations - LIVE case
28 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI with the presence of a mechanical mitral valve.
An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Twenty years of progress - What we have achieved - LIVE case
27 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI by axillary access (Live)
An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Mitral valve in mitral annular calcification (MAC) - Recorded case
27 Nov 2022 – From PCR London Valves 2022
A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...
Ensuring optimal TAVI outcomes - LIVE case
27 Nov 2022 – From PCR London Valves 2022
A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...
Device-closure of challenging atrial septal defects
28 Jun 2022
Watch the replay of this webinar to learn how to select patients suitable for device-closure of atrial septal defects, and much more!
With Lars Sondergaard, Jamie Bentham, Gianfranco Butera and Matthew J. Gillespie
PROTECTED TAVR – Impact on Clinical Practice
03 Oct 2022
Watch the replay of this webinar to understand interpreting PTAVR in a practical manner to reflect clinical practice, and much more!
How to refine my TAVI procedure to ensure optimal long-term patient outcomes? - PCR roundtable discussion
In this video, join Lars Søndergaard, Lenard Conradi and Nicolas Van Mieghem as they discuss the importance of hemodynamic and valve durability in lifetime management of patients with aortic stenosis. You will also learn more about how to ensure coronary access after transcatheter aortic valve implantation...
